Nava Health has pursued going public but has failed, first by withdrawing a traditional IPO in March 2023 due to poor market conditions, and then by terminating a SPAC merger deal with 99 Acquisition Group in September 2024. The initial IPO was planned for the Nasdaq under the ticker NAVA but was withdrawn. Later, a SPAC merger was planned but ultimately terminated after issues with funding and shareholder approval.
Address 9755 Patuxent Woods Drive Suite 100 Columbia, MD 21046
Phone Number (410) 910-6156
Employees: 90
Founded: 2013
Web Address http://www.navacenter.com/
Nava specializes in bio-identical hormone optimization, medically supervised weight loss programs, Platelet Rich Plasma (PRP) procedures, digestive health programs, advanced diagnostic testing, IV micro-nutrient therapy, hyperbaric oxygen therapy, light therapy, intelligent bioenergetics therapy, B-12 injections, Botox injections, dermal fillers, body sculpting and a full line of premium-grade nutraceuticals, supplements and skin health/ aesthetic products. Nava Medical also has a fully equipped in-office clinical laboratory that provides diagnostic testing for Nava’s clients, conveniently increasing the speed of research and results. Lab tests include, but are not limited to, chemistry, hematology, immunoassay, genetic, allergy, food sensitivity and other blood and urine panels.
No comments:
Post a Comment